Related Experiment Video
Updated: Apr 24, 2026
10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10.3K
Site-specific clinical disease onset in multiple sclerosis.
M D Willis1, K E Harding, M Wardle
1Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Heath Park, Cardiff, UK.
European Journal of Neurology
|September 9, 2014
Summary
Multiple sclerosis relapses may not be random. The location and symptoms of a patient's first multiple sclerosis (MS) relapse depend on the initial event, offering insights into disease progression.
Area of Science:
- Neurology
- Immunology
- Neuroscience
Background:
- Multiple sclerosis is a chronic CNS inflammatory disorder.
- Characterized by demyelination and neurological dysfunction.
- Symptomatic relapses are typically viewed as random events.
Purpose of the Study:
- Investigate if multiple sclerosis relapses follow a predetermined sequence.
- Explore if relapses offer insights into pathological processes.
- Analyze the relationship between index events and subsequent relapses.
Main Methods:
- Prospective clinical database analysis of 1482 patients.
- Inclusion of patients with one or more consecutive relapses.
- Regression analysis comparing index event characteristics with first relapse.
Main Results:
- Subsequent relapses are dependent on the index event characteristics.
- Anatomical sites involved in the index event are more likely to be affected in the first relapse.
- Similar associations observed when comparing by symptoms.
Conclusions:
- Findings are crucial for understanding multiple sclerosis evolution.
- Predicting individual disease progression may be enhanced.
- Aids in patient counseling and management strategies.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
9
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
9
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
21
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
21
01:22Myasthenia Gravis ll: Pathophysiology
34
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
34
01:25Endocarditis II: Clinical Features of Infective Endocarditis
918
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
918
01:24Parkinson Disease ll: Pathophysiology
16
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
16